GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Arovella Therapeutics Ltd (STU:E4NA) » Definitions » 3-Year Book Growth Rate

Arovella Therapeutics (STU:E4NA) 3-Year Book Growth Rate : -45.70% (As of Dec. 2023)


View and export this data going back to 2013. Start your Free Trial

What is Arovella Therapeutics 3-Year Book Growth Rate?

Arovella Therapeutics's Book Value per Share for the quarter that ended in Dec. 2023 was €0.00.

During the past 12 months, Arovella Therapeutics's average Book Value per Share Growth Rate was -50.00% per year. During the past 3 years, the average Book Value per Share Growth Rate was -45.70% per year. During the past 5 years, the average Book Value per Share Growth Rate was -51.30% per year. During the past 10 years, the average Book Value per Share Growth Rate was -34.20% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Book Value per Share growth rate.

During the past 13 years, the highest 3-Year average Book Value per Share Growth Rate of Arovella Therapeutics was 40.10% per year. The lowest was -53.90% per year. And the median was -19.80% per year.


Competitive Comparison of Arovella Therapeutics's 3-Year Book Growth Rate

For the Biotechnology subindustry, Arovella Therapeutics's 3-Year Book Growth Rate, along with its competitors' market caps and 3-Year Book Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Arovella Therapeutics's 3-Year Book Growth Rate Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Arovella Therapeutics's 3-Year Book Growth Rate distribution charts can be found below:

* The bar in red indicates where Arovella Therapeutics's 3-Year Book Growth Rate falls into.



Arovella Therapeutics 3-Year Book Growth Rate Calculation

This is the 3-year average growth rate of Book Value per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Book Value per Share growth rate.


Arovella Therapeutics  (STU:E4NA) 3-Year Book Growth Rate Explanation

Book Value per Share is the ratio of equity available to common shareholders divided by the shares outstanding. Book value per share effectively indicates a firm's net asset value on a per-share basis. It can be used by investors to gauge whether a stock price is undervalued by comparing it to the firm's market value per share. Theoretically, it is what the shareholders will receive if the company is liquidated.


Arovella Therapeutics 3-Year Book Growth Rate Related Terms

Thank you for viewing the detailed overview of Arovella Therapeutics's 3-Year Book Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.


Arovella Therapeutics (STU:E4NA) Business Description

Traded in Other Exchanges
Address
62 Lygon Street, Level 3, Carlton, WA, AUS, 3053
Arovella Therapeutics Ltd is a biotechnology company focused on developing therapies to treat human diseases. Its two focus areas are oncology and conditions that impact the central nervous system. The company's principal activity is the pharmaceutical development of its invariant Natural Killer T (iNKT) cell platform for the treatment of cancer.

Arovella Therapeutics (STU:E4NA) Headlines

No Headlines